Robert Thimme
#127,323
Most Influential Person Now
Researcher
Robert Thimme's AcademicInfluence.com Rankings
Robert Thimmebiology Degrees
Biology
#8146
World Rank
#11180
Historical Rank
Virology
#175
World Rank
#180
Historical Rank
Immunology
#459
World Rank
#476
Historical Rank

Download Badge
Biology
Why Is Robert Thimme Influential?
(Suggest an Edit or Addition)Robert Thimme's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection (2001) (1261)
- CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection (2003) (889)
- Genomic analysis of the host response to hepatitis C virus infection (2002) (846)
- Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease (2002) (693)
- Autosomal-dominant immune dysregulation syndrome in humans with CTLA4 mutations (2014) (672)
- Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. (2010) (621)
- T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections. (2016) (590)
- Natural history of chronic hepatitis B virus infection (2015) (565)
- Genomic analysis of the host response to hepatitis B virus infection. (2004) (557)
- TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection (2019) (443)
- T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection (2005) (438)
- Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+ T Cells Is Linked to Antigen Recognition and T Cell Differentiation (2010) (381)
- Differential CD4+ and CD8+ T‐cell responsiveness in hepatitis C virus infection (2001) (364)
- A lymphotoxin-driven pathway to hepatocellular carcinoma. (2009) (350)
- Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties (2010) (341)
- Pathogenesis of hepatitis B virus infection. (2007) (308)
- Immunodominance and functional alterations of tumor‐associated antigen‐specific CD8+ T‐cell responses in hepatocellular carcinoma (2014) (272)
- A global scientific strategy to cure hepatitis B. (2019) (253)
- The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. (2017) (248)
- Innate and adaptive immune responses in HCV infections. (2014) (243)
- Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells (2020) (236)
- Induction of MxA Gene Expression by Influenza A Virus Requires Type I or Type III Interferon Signaling (2007) (230)
- Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis. (2016) (230)
- Dominant influence of an HLA‐B27 restricted CD8+ T cell response in mediating HCV clearance and evolution (2006) (224)
- Restoration of HCV-specific CD8+ T cell function by interferon-free therapy. (2014) (222)
- Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees (2004) (213)
- Colonoscopic full-thickness resection using an over-the-scope device: a prospective multicentre study in various indications (2017) (206)
- Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. (2014) (203)
- Expression of the Interleukin-7 Receptor Alpha Chain (CD127) on Virus-Specific CD8+ T Cells Identifies Functionally and Phenotypically Defined Memory T Cells during Acute Resolving Hepatitis B Virus Infection (2006) (201)
- Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine (2021) (200)
- Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (2018) (187)
- Functional classification of memory CD8+ T cells by CX3CR1 expression (2015) (185)
- Hepatic immune regulation and its involvement in viral hepatitis infection. (2014) (176)
- Intrahepatic CD8+ T‐cell failure during chronic hepatitis C virus infection (2005) (173)
- Antiviral and Regulatory T Cell Immunity in a Patient with Stromal Interaction Molecule 1 Deficiency (2012) (172)
- Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. (2000) (171)
- Increased Expression of the NK Cell Receptor KLRG1 by Virus-Specific CD8 T Cells during Persistent Antigen Stimulation (2005) (171)
- TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation (2017) (161)
- Human Th17 Cells Express High Levels of Enzymatically Active Dipeptidylpeptidase IV (CD26) (2012) (154)
- T cell responses in hepatitis C: the good, the bad and the unconventional (2011) (146)
- Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH (2021) (140)
- Failure of innate and adaptive immune responses in controlling hepatitis C virus infection. (2012) (139)
- Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions (2021) (139)
- T cell response in hepatitis C virus infection. (2005) (138)
- Hepatitis C virus-induced hepatocarcinogenesis. (2009) (137)
- Analysis of CD127 and KLRG1 Expression on Hepatitis C Virus-Specific CD8+ T Cells Reveals the Existence of Different Memory T-Cell Subsets in the Peripheral Blood and Liver (2006) (135)
- A target on the move: innate and adaptive immune escape strategies of hepatitis C virus. (2006) (135)
- Virological and immunological determinants of intrahepatic virus‐specific CD8+ T‐cell failure in chronic hepatitis C virus infection (2008) (134)
- Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response. (2009) (128)
- GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis. (2019) (120)
- HBV life cycle and novel drug targets (2011) (117)
- Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies. (2018) (117)
- Potential of immunotherapy for hepatocellular carcinoma. (2011) (115)
- Uptake and presentation of hepatitis C virus-like particles by human dendritic cells. (2005) (106)
- Comprehensive Intestinal T Helper Cell Profiling Reveals Specific Accumulation of IFN-&ggr;+IL-17+Coproducing CD4+ T Cells in Active Inflammatory Bowel Disease (2014) (105)
- Dissecting the divergent effects of interferon-alpha on immune cells: time to rethink combination therapy in chronic hepatitis B? (2013) (102)
- Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells (2008) (99)
- Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load (2019) (98)
- Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model. (2009) (96)
- CD161 expression on hepatitis C virus–specific CD8+ T cells suggests a distinct pathway of T cell differentiation (2008) (94)
- Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain (2008) (92)
- Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction (2014) (92)
- Transfusion-transmitted hepatitis E in Germany, 2013. (2014) (88)
- Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection. (2011) (87)
- Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants (2021) (85)
- MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD. (2014) (84)
- Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection. (2019) (82)
- Parallel Expansion of Human Virus-Specific FoxP3− Effector Memory and De Novo-Generated FoxP3+ Regulatory CD8+ T Cells upon Antigen Recognition In Vitro1 (2007) (80)
- Hepatitis C Virus (HCV) Sequence Variation Induces an HCV-Specific T-Cell Phenotype Analogous to Spontaneous Resolution (2009) (79)
- Tracking Virus-Specific CD4+ T Cells during and after Acute Hepatitis C Virus Infection (2007) (78)
- Endoscopic full-thickness resection for early colorectal cancer. (2019) (76)
- T-cell responses in hepatitis B and C virus infection: similarities and differences (2013) (73)
- Serum markers of hepatocellular carcinoma. (2006) (71)
- Analysis of the Evolutionary Forces in an Immunodominant CD8 Epitope in Hepatitis C Virus at a Population Level (2008) (70)
- Targeted therapy for hepatocellular carcinoma (2009) (70)
- Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection (2021) (69)
- The Role of Natural Killer Cells and CD8+ T Cells in Hepatitis B Virus Infection (2014) (68)
- Analysis of CD8+ T cell-mediated inhibition of hepatitis C virus replication using a novel immunological model (2009) (67)
- Adaptive immune responses in hepatitis C virus infection. (2013) (66)
- Regulatory T cells in viral hepatitis. (2007) (65)
- Comprehensive analysis of the α‐fetoprotein‐specific CD8+ T cell responses in patients with hepatocellular carcinoma (2008) (65)
- T Cells with a CD 4 CD 25 Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD 8 T Cells during Chronic Hepatitis C Virus Infection (2005) (64)
- Diarrhea predicts a positive response to sorafenib in patients with advanced hepatocellular carcinoma (2012) (64)
- Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype‐specific immunodominant CD8+ T‐cell epitope (2010) (61)
- Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections. (2016) (59)
- Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in Hepatocytes. (2018) (58)
- Immunodominance of HLA-A2-Restricted Hepatitis C Virus-Specific CD8+ T Cell Responses Is Linked to Naïve-Precursor Frequency (2011) (58)
- First-line endoscopic treatment with over-the-scope clips significantly improves the primary failure and rebleeding rates in high-risk gastrointestinal bleeding: A single-center experience with 100 cases (2016) (58)
- Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID‐19: coincidence or underestimated risk factor? (2020) (57)
- Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation (2020) (56)
- Escape from HLA-B*08-Restricted CD8 T Cells by Hepatitis C Virus Is Associated with Fitness Costs (2008) (56)
- Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine (2008) (54)
- β2-Microglobulin deficiency causes a complex immunodeficiency of the innate and adaptive immune system. (2015) (53)
- The Burden of Hepatitis E among Patients with Hematological Malignancies: a Retrospective European Cohort Study. (2019) (52)
- In Vivo Study of the HC-TN Strain of Hepatitis C Virus Recovered from a Patient with Fulminant Hepatitis: RNA Transcripts of a Molecular Clone (pHC-TN) Are Infectious in Chimpanzees but Not in Huh7.5 Cells (2007) (51)
- Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations (2011) (51)
- OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection. (2019) (50)
- Active Maintenance of T Cell Memory in Acute and Chronic Viral Infection Depends on Continuous Expression of FOXO1. (2018) (50)
- Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection. (2007) (50)
- Mx1 but not MxA confers resistance against tick-borne Dhori virus in mice. (1995) (49)
- [ALT screening for chronic liver diseases: scrutinizing the evidence]. (2010) (49)
- Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency. (2014) (48)
- Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture (2016) (48)
- On‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi‐centre, prospective study (2017) (47)
- Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks. (2011) (47)
- Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients (2015) (47)
- Full-Thickness-Resection-Device (FTRD) (2015) (46)
- Procedural and shunt‐related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS) (2016) (44)
- Rapid and simple detection of IFN‐neutralizing antibodies in chronic hepatitis C non‐responsive to IFN‐α (2006) (43)
- The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression (2019) (43)
- Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo. (2013) (42)
- Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial (2019) (41)
- Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma (2017) (41)
- The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice (2013) (41)
- Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin. (2012) (41)
- Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells (2018) (39)
- SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis (2022) (39)
- CD8+ regulatory T cells in persistent human viral infections. (2008) (39)
- IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals (2020) (39)
- Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival. (2021) (39)
- The albumin–bilirubin grade improves hepatic reserve estimation post‐sorafenib failure: implications for drug development (2017) (36)
- Cellular Immune Responses to Hepatocellular Carcinoma: Lessons for Immunotherapy (2012) (36)
- Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection (2007) (35)
- TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection (2020) (35)
- Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. (2008) (35)
- Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma (2015) (35)
- Immune-surveillance through exhausted effector T-cells. (2016) (34)
- Hepatitis B or hepatitis C and human immunodeficiency virus infection. (2005) (34)
- Identification of Five Different Patr Class I Molecules That Bind HLA Supertype Peptides and Definition of Their Peptide Binding Motifs1 (2000) (34)
- Degenerate Immunogenicity of an HLA-A2-Restricted Hepatitis B Virus Nucleocapsid Cytotoxic T-Lymphocyte Epitope That Is Also Presented by HLA-B51 (2001) (34)
- Role of Host Genetic Factors in the Outcome of Hepatitis C Virus Infection (2009) (33)
- HCV-Specific T Cell Responses During and After Chronic HCV Infection (2018) (33)
- Heterogeneity of HBV-Specific CD8+ T-Cell Failure: Implications for Immunotherapy (2019) (32)
- Hepatitis C virus recombinants are rare even among intravenous drug users (2010) (32)
- Hepatitis B virus: from immunobiology to immunotherapy. (2013) (32)
- Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study (2019) (31)
- Follicular T helper cells shape the HCV-specific CD4 T cell repertoire after viral elimination. (2019) (31)
- CD161+CD4+ T cells are enriched in the liver during chronic hepatitis and associated with co-secretion of IL-22 and IFN-γ (2012) (31)
- CD8+ T-Cell Responses in Hepatitis B and C: The (HLA-) A, B, and C of Hepatitis B and C (2016) (30)
- Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level (2019) (30)
- Immunological cure of HBV infection (2019) (30)
- Success and Failure of Virus-Specific T Cell Responses in Hepatitis C Virus Infection (2011) (29)
- HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope. (2014) (29)
- Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-alpha. (2006) (29)
- NK-cell responses are biased towards CD16-mediated effector functions in chronic hepatitis B virus infection. (2019) (28)
- Compensatory Mutations Restore the Replication Defects Caused by Cytotoxic T Lymphocyte Escape Mutations in Hepatitis C Virus Polymerase (2011) (28)
- Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis (2018) (27)
- Experimental models to study the immunobiology of hepatitis C virus. (2011) (26)
- MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance. (2019) (26)
- Rapid Antigen Processing and Presentation of a Protective and Immunodominant HLA-B*27-restricted Hepatitis C Virus-specific CD8+ T-cell Epitope (2012) (26)
- Absence of viral escape within a frequently recognized HLA-A26-restricted CD8+ T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage site. (2007) (26)
- Vitamin D inhibits pro-inflammatory T cell function in patients with inflammatory bowel disease. (2019) (26)
- Differential antigen specificity of hepatitis C virus-specific interleukin 17- and interferon γ-producing CD8(+) T cells during chronic infection. (2012) (25)
- Lack of ex vivo peripheral and intrahepatic α‐fetoprotein‐specific CD4+ responses in hepatocellular carcinoma (2011) (24)
- Overcoming CD8+ T-Cell Exhaustion in Viral Hepatitis: Lessons from the Mouse Model and Clinical Perspectives (2017) (24)
- Hepatitis B Virus-Infected HepG2hNTCP Cells Serve as a Novel Immunological Tool To Analyze the Antiviral Efficacy of CD8+ T Cells In Vitro (2015) (24)
- Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154. (2010) (23)
- Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis (2018) (22)
- Immunobiology of hepatocellular carcinoma (2012) (22)
- Evolving therapies in the treatment of hepatocellular carcinoma (2008) (22)
- TGF‐β downregulates KLRG1 expression in mouse and human CD8+ T cells (2015) (22)
- Hepitopes: A live interactive database of HLA class I epitopes in hepatitis B virus (2016) (22)
- Host cell responses induced by hepatitis C virus binding (2006) (21)
- Perspectives of immunotherapy in hepatocellular carcinoma (HCC) (2016) (21)
- [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature]. (2009) (21)
- T cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma. (2022) (21)
- Host genetics in immune-mediated hepatitis C virus clearance. (2011) (21)
- Analysis of bulk and virus-specific CD8+ T cells reveals advanced differentiation of CD8+ T cells in patients with common variable immunodeficiency. (2011) (21)
- CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c‐jun N terminal kinase activation independent from the interferon pathway (2013) (20)
- The role of albumin–bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy (2018) (20)
- In vivo proof of concept of adoptive immunotherapy for hepatocellular carcinoma using allogeneic suicide gene-modified killer cells. (2014) (20)
- A prospective, multicentre study in acute non‐cirrhotic, non‐malignant portal vein thrombosis: comparison of medical and interventional treatment (2020) (20)
- Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study (2017) (20)
- Bridging basic science and clinical research: the EASL Monothematic Conference on Translational Research in Viral Hepatitis. (2014) (20)
- First report of invasive liver abscess syndrome with endophthalmitis caused by a K2 serotype ST2398 hypervirulent Klebsiella pneumoniae in Germany, 2016 (2017) (19)
- Extracellular ATP and purinergic P2Y2 receptor signaling promote liver tumorigenesis in mice by exacerbating DNA damage. (2019) (19)
- Tetramer Enrichment Reveals the Presence of Phenotypically Diverse Hepatitis C Virus-Specific CD8+ T Cells in Chronic Infection (2014) (19)
- Role of Immunity in Pathogenesis and Treatment of Hepatocellular Carcinoma (2016) (19)
- Synergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infection (2013) (19)
- Tumor-associated antigen specific CD8+ T cells in hepatocellular carcinoma – a promising target for immunotherapy (2014) (19)
- Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential. (2012) (18)
- T cell immunity to hepatitis C virus: lessons for a prophylactic HCV vaccine. (2020) (18)
- Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience (2017) (18)
- Selenium levels in patients with hepatitis C virus‐related chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma: A pilot study (2013) (18)
- Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS) (2018) (17)
- Treatment with proton pump inhibitors is associated with increased mortality in patients with pyogenic liver abscess (2018) (17)
- COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation (2022) (17)
- Vitamin D Levels Vary during Antiviral Treatment but Are Unable to Predict Treatment Outcome in HCV Genotype 1 Infected Patients (2014) (17)
- Chronic hepatitis E virus infection following allogeneic hematopoietic stem cell transplantation: an important differential diagnosis for graft versus host disease (2015) (17)
- [COVID-19 associated pneumonia despite repeatedly negative PCR-analysis from oropharyngeal swabs]. (2020) (16)
- SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals (2022) (16)
- Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination (2021) (16)
- [Pyogenic liver abscess: Changes of Organisms and Consequences for Diagnosis and Therapy]. (2017) (15)
- Natural killer cells and hepatitis C: Natural killer p46 expression linked to antiviral and antifibrotic activity (2012) (15)
- CD8+ T Cell Responses during HCV Infection and HCC (2021) (15)
- Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis. (2017) (15)
- Suppressive effect of interleukin 10 on priming of naive hepatitis C virus-specific CD8+ T cells. (2015) (14)
- 2007 4 WEEK THERAPY WITH THE NON-NUCLEOSIDIC POLYMERASE INHIBITOR BI207127 IN COMBINATION WITH PEGINTERFERON-ALFA2A AND RIBAVIRIN IN TREATMENT NAIVE AND TREATMENT EXPERIENCED CHRONIC HCV GT1 PATIENTS (2010) (14)
- Advances in prevention and diagnosis of hepatocellular carcinoma (2008) (14)
- Vacuum sponge therapy using the pull-through technique via a percutaneous endoscopic gastrostomy to treat iatrogenic duodenal perforation (2015) (14)
- IL-2 contributes to cirrhosis-associated immune dysfunction by impairing follicular T helper cells in advanced cirrhosis. (2020) (14)
- Acute pancreatitis and vasoplegic shock associated with leptospirosis – a case report and review of the literature (2019) (14)
- Ampullary Hamartoma: A Rare Cause of Biliary Obstruction (1999) (14)
- Inefficient induction of circulating TAA-specific CD8+ T-cell responses in hepatocellular carcinoma (2019) (13)
- Serum protein profiling reveals a specific upregulation of the immunomodulatory protein progranulin in COVID-19 (2020) (13)
- Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study (2020) (13)
- Determinants of in vitro expansion of different human virus-specific FoxP3+ regulatory CD8+ T cells in chronic hepatitis C virus infection. (2009) (13)
- Ex vivo detection of SARS-CoV-2-specific CD8+ T cells: rapid induction, prolonged contraction, and formation of functional memory (2020) (13)
- Two-sided sponge (TSS) treatment: Description of a novel device and technique for endoscopic vacuum treatment (EVT) in the upper gastrointestinal tract (2016) (12)
- Adaptive Immune Response against Hepatitis C Virus (2020) (12)
- Ustekinumab Inhibits T Follicular Helper Cell Differentiation in Patients With Crohn’s Disease (2020) (12)
- Nonsurgical Therapeutic Options in Portal Vein Thrombosis (2014) (12)
- Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis (2018) (12)
- Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections. (2019) (12)
- Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency (2021) (12)
- 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two (2016) (11)
- Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma (2018) (11)
- Entering the spotlight: hepatitis B surface antigen-specific B cells. (2018) (11)
- Interleukin-10 and viral clearance: translation to viral hepatitis. (2007) (11)
- ERAP1 allotypes shape the epitope repertoire of virus-specific CD8+ T cell responses in acute hepatitis C virus infection (2019) (11)
- [Perspectives on immunotherapy for hepatocellular carcinoma]. (2013) (11)
- ‘Stem-like’ precursors are the fount to sustain persistent CD8+ T cell responses (2022) (11)
- [COVID-19-Response - Strategies of the Task-Force Coronavirus and experiences upon implementation in the management of 115 cases at the University Medical Center Freiburg]. (2020) (10)
- HCV research 20 years after discovery: a summary of the 16th international symposium on hepatitis C virus and related viruses. (2010) (10)
- [Hepatocellular carcinoma - from immunobiology to immunotherapy]. (2012) (10)
- Methodologies for the Analysis of HCV-Specific CD4+ T Cells (2015) (10)
- Mutational escape from cellular immunity in viral hepatitis: variations on a theme. (2021) (9)
- Outcome of Antiviral Immunity in the Liver Is Shaped by the Level of Antigen Expressed in Infected Hepatocytes (2018) (9)
- Addressing the next challenges: A summary of the 22nd international symposium on hepatitis C virus and related viruses. (2016) (9)
- Neoantigens as potential vaccines in hepatocellular carcinoma (2022) (9)
- Over-the-scope clips are cost-effective in recurrent peptic ulcer bleeding (2019) (9)
- Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variability. (2009) (9)
- Deep Spatial Profiling of COVID-19 Brains Reveals Neuroinflammation by Compartmentalized Local Immune Cell Interactions and Targets for Intervention (2020) (9)
- Resection of a large rectal polyp with the simultaneous combination of snare polypectomy and full-thickness resection device resection (2015) (9)
- Severe Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt ( TIPS ) : Value of Shunt Reduction and Occlusion (2017) (9)
- 54 COMPLETELY INDIVIDUALIZED TREATMENT DURATIONS (24, 30, 36, 42, 48, 60 OR 72 WEEKS) WITH PEGINTERFERON-ALFA-2B AND RIBAVIRIN IN HCV GENOTYPE 1-INFECTED PATIENTS (INDIV-2 STUDY) (2010) (9)
- Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses (2021) (8)
- Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study (2021) (8)
- Immunotherapy and therapeutic vaccines for chronic HBV infection. (2021) (8)
- Adjuvant Transjugular Variceal Occlusion at Creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS): Efficacy and Risks of Bucrylate Embolization (2019) (8)
- Successful two-sided sponge pull-through treatment of anastomotic leakage following pancreaticoduodenectomy with pancreaticogastrostomy (2017) (8)
- Highlights from Hepatology 2015: From Chronic Hepatitis to Hepatocellular Carcinoma (2016) (8)
- Reduction of esophageal stent migration rate with a novel over-the-scope fixation device. (2022) (8)
- Differential virus‐specific CD8+ T‐cell epitope repertoire in hepatitis C virus genotype 1 versus 4 (2018) (7)
- Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (2018) (7)
- MAIT be different–persisting dysfunction after DAA‐mediated clearance of chronic hepatitis C virus infection (2016) (7)
- Influence of the transjugular intrahepatic portosystemic stent on firstline treatment of hepatocellular carcinoma (2013) (7)
- All oral fixed-dose combination Sofosbuvir/Ledipasvir with or without Ribavirin for 12 or 24 weeks in treatment-naive genotype 1 HCV-infected patients: the phase 3 ION-1 study (2014) (7)
- CD4+ T cell responses in human viral infection: lessons from hepatitis C. (2020) (7)
- Prognostic Value of the CLIF‐C AD Score in Patients With Implantation of Transjugular Intrahepatic Portosystemic Shunt (2021) (7)
- Trailblazing Precision Medicine in Europe: a joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany. (2021) (6)
- Memory vs memory‐like: The different facets of CD8+ T‐cell memory in HCV infection (2018) (6)
- Toll like receptor 7 and hepatitis C virus infection. (2007) (6)
- Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational study (2017) (6)
- Unique and common features of innate-like human V[delta]2+ [gamma][delta]T cells and mucosal-associated invariant T cells (2018) (6)
- 54 Endoscopic Full-Thickness Resection in the Colorectum Using an Over-the-Scope Device - Interim Results of a Prospective Multicenter Study (2016) (5)
- Tracking cccDNA in chronic HBV infection (2004) (5)
- Antiviral Therapy in Hepatitis B Virus-Associated Liver Cirrhosis (2015) (5)
- For whom the interferons toll - TLR7 mediated boosting of innate and adaptive immunity against chronic HBV infection. (2018) (5)
- Ribavirin ante portas: uptake transporters into hepatocytes dissected. (2010) (5)
- Phase II HEPANOVA trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma. (2019) (5)
- End of the story: direct-acting antiviral agents are not associated with recurrence of hepatocellular carcinoma (2021) (5)
- Comprehensive analysis of the α-Fetoprotein specific CD8+ T cell responses in patients with hepatocellular carcinoma (2008) (5)
- SYNERGISM OF TAPASIN AND HLA IN RESOLVING HCV INFECTION (2013) (5)
- [Hepatology 2009]. (2009) (5)
- Discordance of hepatitis B vaccination policies for healthcare workers between the USA, the UK, and Germany (2019) (5)
- Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma (2021) (5)
- Immune responses against HCV‐NS3 after accidental infection with HCV‐NS3 recombinant vaccinia virus (2007) (4)
- [Complications of liver cirrhosis - pharmaceutical versus interventional therapy]. (2019) (4)
- Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection (2022) (4)
- Kill, control, or escape: Immune responses in viral hepatitis (2016) (4)
- Endoscopic submucosal dissection of an esophageal granular cell tumor (2019) (4)
- The cyclophilin-inhibitor alisporivir stimulates antigen presentation thereby promoting antigen-specific CD8+ T cell activation (2016) (4)
- Rapid and stable mobilization of fully functional spike-specific CD8+ T cells preceding a mature humoral response after SARS-CoV-2 mRNA vaccination (2021) (4)
- Vaccine‐induced hepatitis C virus‐specific CD8+ T cells do not always help (2015) (4)
- Endoscopic full-thickness resection and its treatment alternatives in difficult-to-treat lesions of the lower gastrointestinal tract: a cost-effectiveness analysis (2020) (4)
- Sorafenib Promotes Graft-Versus-Leukemia Activity in Mice and Humans through IL-15 Production in Leukemia Cells (2016) (4)
- Hepatozelluläres Karzinom: neue multimodale Therapiekonzepte (2018) (4)
- [Genome-wide association studies]. (2011) (4)
- Standardtherapie der chronischen Hepatitis B (2006) (3)
- [Therapy of hepatitis B]. (2006) (3)
- [The hepatocellular carcinoma: alternative therapeutical strategies]. (2007) (3)
- Addition of pegylated interferon alfa-2a to an ongoing nucleos(t) ide treatment accelerates decrease of HBs-antigen levels in patients with chronic hepatitis B: Results from the PADD-ON study (2018) (3)
- Fatal ulcerative enteritis of the small intestine in a patient with ulcerative colitis treated with vedolizumab (2017) (3)
- ERAP 1 allotypes shape the epitope repertoire of virus-specific CD 8 + T cell responses in acute hepatitis C virus infection Graphical (2019) (3)
- [Hepatitis B and C: from molecular virology to new antiviral therapies (part 2)]. (2014) (3)
- 642 INDIVIDUALIZED TREATMENT DURATION WITH PEGINTERFERON-ALFA-2B AND RIBAVIRIN FOR 24, 30 OR 36 WEEKS IN HCV GENOTYPE1-INFECTED PATIENTS WITH UNDETECTABLE HCV-RNA EARLY DURING THERAPY (INDIV-2 STUDY) (2009) (3)
- Abnormally differentiated CD 4 1 or CD 8 1 T cells with phenotypic and genetic features of double negative T cells in human Fas de fi ciency (2014) (3)
- Immunity to hepatitis C virus infection: Update 2007 (2007) (3)
- CD8+ T-cell differentiation in chronic HCV infection (2011) (3)
- NKp46+ expression on NK cells as a biomarker for liver pathology and IFN-responiveness in HCV infection (2013) (3)
- Comparison of the Covered Self-Expandable Viatorr CX Stent with the Covered Balloon-Expandable BeGraft Peripheral Stent for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation: a Single-Centre Retrospective Study in Patients with Variceal Bleeding (2022) (3)
- Ischemic Duodenal Ulceration after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Case Report (2018) (3)
- [Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)]. (2014) (3)
- Over‐the‐scope clip versus transcatheter arterial embolization for refractory peptic ulcer bleeding—A propensity score matched analysis (2021) (3)
- Validation of color Doppler ultrasound and computed tomography in the radiologic assessment of non-malignant acute splanchnic vein thrombosis (2021) (3)
- High-Fructose Diet Alters Intestinal Microbial Profile and Correlates with Early Tumorigenesis in a Mouse Model of Barrett’s Esophagus (2021) (3)
- Karrierewege in der Hochschulmedizin in Deutschland (2009) (3)
- [Clinical management of patients with new diagnosis of liver cirrhosis]. (2019) (3)
- [Career path in German university medicine]. (2009) (3)
- [The role of the virus specific T-cell response in acute and chronic HBV and HCV infection]. (2004) (3)
- A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort (2016) (3)
- Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study) (2021) (3)
- [Cure of chronic Hepatitis B and C: vision versus reality]. (2015) (3)
- Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells (2020) (3)
- Serological diagnosis of early HCC in NASH: A German multicenter study (2018) (3)
- [Hepatology 2010]. (2010) (3)
- Toward a Better Understanding of Hepatocellular Carcinoma Immune Infiltrates (2019) (3)
- [30 Years of Transjugular Intrahepatic Portosystemic Shunt (TIPS): casting a retrospective glance and future perspectives]. (2020) (3)
- [Direct antiviral treatment strategies in chronic hepatitis C]. (2012) (2)
- [Structured Career Pathways in the University Medicine - From Promotion to Clinician Scientist Programs]. (2019) (2)
- Differences in the source sequence of two HCV genotype 1b outbreaks within immunodominant CD8 epitopes are associated with differential outcome (2010) (2)
- [Viral anti-interferon strategies: mechanisms and clinical impact]. (2003) (2)
- iNKT cells in chronic HBV: a balancing act (2016) (2)
- [Acute hepatitis C. Therapy with interferon alpha-2b]. (2002) (2)
- Is Sorafenib an acceptable treatment possibility for patients with advanced hepatocellular carcinoma (2012) (2)
- Balance lost: T cell immunity in progressive HBV infection (2014) (2)
- [A case of idiopathic postinfantile giant cell hepatitis treated with a calcineurin inhibitor]. (2021) (2)
- Double-scope resection of a large duodenal polyp (2015) (2)
- Success of immune checkpoint blockade therapies – mechanisms and implications for hepatology (2019) (2)
- Bulevirtide treatment of hepatitis D in Germany: multicentre real-world experience (2022) (2)
- Role of Immunomodulators in Functional Cure Strategies for HBV (2020) (2)
- [T-cell response against viruses. A new non-cytotoxic antiviral strategy]. (2009) (2)
- [T cell response to hepatitis B and C: from viral elimination to hepatocellular carcinoma]. (2002) (2)
- Current status of endoscopic full‐thickness resection with the full‐thickness resection device (2022) (2)
- Mechanisms of CD8+ T cell failure in chronic hepatitis E virus infection. (2022) (2)
- Use of the full-thickness resection device (FTRD) to prevent bleeding after colonic polypectomy in a patient with a left ventricular assist device (2017) (2)
- [Hepatocellular Carcinoma: therapeutic options 2015]. (2015) (2)
- the existence of different memory T cell subsets in the peripheral blood and liver 2 3 (2006) (2)
- High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature (2022) (2)
- Endoskopische Vollwandresektion im Kolorektum mit dem Full-Thickness Resection Device (FTRD): Eine prospektive multizentrische Studie („WALL RESECT“) (2016) (2)
- Hepatitis B vaccine and NK cells: a new player in memory (2020) (2)
- The protective effect of HLA-B27 in hepatitis C virus infection requires presence of a genotype-specific immunodominant CD8+ T cell epitope (2009) (2)
- Management of Portal/Mesenteric Vein Thrombosis (2014) (2)
- Granulocyte colony‐stimulating factor (G‐CSF) may stimulate HIV‐replication during cytostatic chemotherapy (1998) (2)
- SARS-CoV-2 specific T cells induced by both SARS-CoV-2 infection and mRNA vaccination broadly cross-recognize omicron (2022) (2)
- [Chronic hepatitis B virus infection: current and future treatment strategies]. (2022) (2)
- Blood reelin in the progression of chronic liver disease. (2021) (2)
- 337 MXA gene expression as a sensitive marker for IFN bioactivity and neutralizing antibodies in chronic hepatitis C virus infection (2003) (2)
- Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection. (2018) (2)
- Outcome of anti-viral immunity in the liver is shaped by the level of antigen expressed in infected hepatocytes (2018) (2)
- Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses? Authors’ reply (2018) (1)
- Implantation of transjugular intrahepatic portosystemic shunt (TIPS): indication and patient selection (2022) (1)
- [Jaundice in an HIV-positive pregnant woman]. (2008) (1)
- [Immunopathogenesis of viral hepatitis]. (2007) (1)
- SARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ Transplants (2023) (1)
- [How to do: Radiofrequency thermal ablation]. (2015) (1)
- Blood cyclic guanosine monophosphate levels as potential marker of portal hypertension in patients with liver cirrhosis (2021) (1)
- Immune-mediated Hepatitis associated with SARS-CoV-2 mRNA vaccination (2022) (1)
- Dominance of cytolytic effector functions in hepatitis B virus-specific CD8+ T cell and NK cell mediated antiviral efficacy using hepatitis B virus infected hepatocytes overexpressing human sodium taurocholate cotransporting polypeptide (2014) (1)
- Akute Hepatitis C Therapie mit Interferon α-2b (2002) (1)
- Exhaustion of CD39-expressing CD8+ T cells in Crohn's disease is linked to clinical outcome. (2022) (1)
- The Immune Response to HCV in Acute and Chronic Infection (2013) (1)
- Another important step toward a prophylactic vaccine against hepatitis C (2022) (1)
- Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study (2021) (1)
- Virushepatitis A–E (2021) (1)
- An uncommon presentation of a common pathogen (2015) (1)
- [COVID-19 associated pneumonia despite repeatedly negative PCR-analysis from oropharyngeal swabs]. (2020) (1)
- Immunopathology caused by impaired CD8+ T‐cell responses (2022) (1)
- [Cellular immune response in Hepatitis C infection: role of CD154 expression and clinical relevance]. (2011) (1)
- [Chronic hepatitis B]. (2008) (1)
- Rheumatological Patients are at Risk of Chronic HEV Infection: A Multicentric European Study (2016) (1)
- [Best supportive care of hepatocellular carcinoma]. (2004) (1)
- Abstract CT186: HEPANOVA: Interim safety analysis from a phase 2 study of Tumor Treating Fields (TTFields, 150 kHz) concomitant with sorafenib in advanced hepatocellular carcinoma (HCC) (2020) (1)
- A rare cause of upper GI bleeding in a critically ill patient (2015) (1)
- ERAP1 allotypes impact the epitope repertoire of virus-specific CD8+ T cell responses in acute hepatitis C virus infection (2019) (1)
- Differenzial functional enhancement of HBV-specific CD8+ T cell upon inhibitory receptor blockade (2013) (1)
- IL28B genotype and hepatitis C virus specific T cell response (2011) (1)
- Postgraduate Course: Integrating Basic Science into Clinical Practice (2010) (1)
- Bridge over troubled water: Protection against hepatitis C virus persistence? (2002) (1)
- Virushepatitis – wann daran denken? (2019) (1)
- 2008 DOSE-RANGING, THREE-DAY MONOTHERAPY STUDY OF THE HCV NS3 PROTEASE INHIBITOR GS-9256 (2010) (1)
- Add on Interferon-Alpha-2a for the treatment of hbeag negative Hepatitis B patients receiving effective nucleos (t)ide therapy: interim results of the prospective multicentre padd-on trial (2016) (1)
- T-Zell-Antwort gegen Viren – Eine neue nicht-zytotoxische antivirale Strategie (2009) (1)
- Metabolic properties of epigenetically regulated adaptive versus conventional NK cells are conserved in chronic viral hepatitis (2017) (1)
- Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure. (2022) (1)
- Hierarchy of inhibitory receptor expression by Hepatitis B Virus (HBV)-specific CD8+ T cells in chronic HBV infection (2012) (1)
- [Hepatitis C with fatigue and polyneuropathy]. (2010) (1)
- Capturing adaptive immunity against SARS-CoV-2 in patients with cancer (2021) (1)
- Prediction of clinical outcome in advanced hepatitis C-associated liver disease: identification of patients at the highest need for antiviral treatment and surveillance (2014) (1)
- [Cholestatic liver diseases]. (2011) (1)
- International multi-center experience of transjugular intrahepatic portosystemic shunt implantation in patients with common variable immunodeficiency. (2021) (1)
- Reply: Freiburg index of post-TIPS survival (FIPS) a valid prognostic score in patients with cirrhosis but also an advisor against TIPS? (2021) (1)
- Erratum: Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture (2017) (1)
- [Therapy of chronic hepatitis B and C virus infections in the clinical practice]. (2012) (1)
- Ribavirin in Acute Hepatitis E Infection in Patients with Gynecological Cancer: A Case Series (2018) (1)
- T cell exhaustion dynamics are linked to clinical outcomes in Hepatocellular Carcinoma (2020) (0)
- [Cholestatic liver disease]. (2016) (0)
- Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency (2021) (0)
- 726 EVALUATION OF THE IMPACT OF BARE-METAL STENT TIPS ON OVERALL SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARINOMA (HCC) (2012) (0)
- [Pancreatic diseases]. (2021) (0)
- Seltene Escapemutationen in einem HLA-B27 restringierten CD8+ T-Zell-Epitop erfordern kompensatorische Mutationen (2010) (0)
- Author Correction: Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH (2021) (0)
- Progression of NAFLD and NASH is mediated by proinflammatory tissue-resident T cells (2020) (0)
- Stereotactic Body Radiotherapy vs Transarterial Chemoembolization In Locally Advanced Hepatocellular Carcinoma (HERACLES: Hepatocellular Carcinoma Stereotactic Radiotherapy Clinical Efficacy Study) (2020) (0)
- Frequency Responses Is Linked to Naïve-Precursor T Cell + Hepatitis C Virus-Specific CD 8 Immunodominance of HLA-A 2-Restricted (2011) (0)
- 783 HBV-SPECIFIC CD8+ T CELLS AND NK CELLS MEDIATE THEIR ANTIVIRAL EFFECT PRIMARILY VIA PERFORIN/GRANZYME DEPENDENT CYTOLYSIS (2012) (0)
- Impact of duodenal-jejunal bypass liner (DJBL) on NAFLD in patients with obesity and type 2 diabetes mellitus. (2022) (0)
- [Structured approach with liver cirrhosis]. (2019) (0)
- Pankreaserkrankungen (2021) (0)
- [Autoimmune Hepatitis - What is important for clinical practice?] (2022) (0)
- P0479 : Naive-like CD8+ T cells specific for subdominant hepatitis B virus epitopes are present in chronically infected patients (2015) (0)
- [Cholestatic liver diseases: diagnosis and therapy of primary biliary cirrhosis]. (2002) (0)
- Over-The-Scope Clips (OTSC) versus Transarterial Angiographic Embolisation (TAE) as salvage therapy for refractory peptic ulcer bleeding - a propensity score matched analysis (2020) (0)
- O.173 Virus-host interactions during the first steps of viral infection: host cell responses induced by cellular binding of hepatitis C virus-like particles (2006) (0)
- [Cholestatic liver diseases]. (2004) (0)
- Chronic HBV Infection Drives Expansion of Adaptive NK Cells (2016) (0)
- Unusual endoscopic treatment of recurrent cough and pneumonia (2018) (0)
- Metabolic programming of exhausted CD8+ T cells in chronic viral hepatitis (2019) (0)
- P92 CD161+ γ-δ T cells: defining their role in patients with and without chronic hepatitis C (2011) (0)
- The spatial distribution and detailed composition of infiltrating immune cells define autoimmune- and checkpoint-therapy associated hepatitis (2022) (0)
- CD8+ T CELL RESPONSE IN ACUTE HCV INFECTION (2014) (0)
- 45 RAPID AND EFFICIENT ANTIGEN PROCESSING AND PRESENTATION OF A PROTECTIVE AND IMMUNODOMINANT HLA-B*27-RESTRICTED HEPATITIS C VIRUS-SPECIFIC CD8+ T CELL EPITOPE (2012) (0)
- Author response: Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients (2015) (0)
- Single cell RNAsequencing derived signature of hepatocyte de-differentiation predicts development of hepatocellular carcinoma in patients with liver cirrhosis (2022) (0)
- 56 Scavenger receptor class B type i mediates uptake and cross-presentation of hepatitis C virus by human dendritic cells (2006) (0)
- Perspectives for novel therapeutic concepts in hepatocellular carcinoma targeting the stromal and innate immune microenvironment (2022) (0)
- CD4 T cell immunity to HEV-infection is characterized by sustained capsid-specific responses that correlate with neutralizing antibodies (2022) (0)
- Regulatory T cells suppress virus-specific CD8+ T cells in chronically hepatitis C virus infected patients (2004) (0)
- Detection of naïve hepatitis C virus-specific CD8+ T cells in chronically infected patients (2013) (0)
- P078 Vitamin D concentrations affect the composition of T-lymphocyte subsets and proinflammatory cytokine production in patients with inflammatory bowel disease (2018) (0)
- Evolving treatments of virus-associated HCC: new targets and drugs. (2010) (0)
- P0491 : Identification of CD8+ T-cell epitopes specific for hepatitis C virus genotype 4 (2015) (0)
- PS-032-Impact of antigen recognition on memory-like HCV-specific CD8+ T-cells (2019) (0)
- [Preclinical and clinical management of patients with acute gastrointestinal bleeding]. (2022) (0)
- 372 HIERARCHY OF INHIBITORY RECEPTOR EXPRESSION BY HEPATITIS B VIRUS (HBV)-SPECIFIC CD8+ T CELLS IN CHRONIC HBV INFECTION (2013) (0)
- Die Hepatitis-E-Virus-Infektion (2020) (0)
- 1350 HOST-SPECIFIC FACTORS INDEPENDENT OF IL28B GENOTYPE PREDICTING TREATMENT OUTCOME OF INDIVIDUALIZED THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 INFECTION (2011) (0)
- Hepatic decompensation after transarterial radioembolization (TARE) – a retrospective analysis of risk factors and outcome of patients with HCC (2022) (0)
- SAT-381-TAA-specific CD8+ T-cell responses are inefficiently induced in hepatocellular carcinoma (2019) (0)
- The Role of Novel Prognostic Scores for Patients With Hepatocellular Carcinoma (2017) (0)
- [Correction: Colorectal carcinoma]. (2021) (0)
- P140 MODELLING THE LIVER IMMUNE MICROENVIRONMENT: FACTORS THAT DEFINE ANTIVIRAL ACTIVITY OF T CELLS (2014) (0)
- Abstract CT175: HEPANOVA Phase II study design for advanced hepatocellular carcinoma: Tumor treating fields concomitant with sorafenib (2019) (0)
- 473 ENDOSCOPIC FULL-THICKNESS RESECTION IN COLORECTAL CANCER (2019) (0)
- Combined OX40 stimulation and PD-L1 blockade reinforce HBV-specific CD4 T cell responses (2019) (0)
- Enforced cytotoxic signature of HBV pol455-specific CD8 T cells in chronic HBV infection (2022) (0)
- [The patient as partner -- observations regarding a respectful relationship with sick people]. (2005) (0)
- Type I Interferons promote maintenance and function of follicular T helper cells in vitro (2019) (0)
- Th1-Biased Hepatitis C Virus-Specific Follicular T Helper-Like Cells Effectively Support B Cells After Antiviral Therapy (2021) (0)
- VΔ1 T Cells Differentiate into Cytotoxic Effector Cells in Chronic Viral Hepatitis (2016) (0)
- O104 CYTOLYTIC EFFECTOR FUNCTIONS PREDOMINATE IN CD8+ T-CELL AND NK-CELL MEDIATED INHIBITION OF VIRAL REPLICATION IN HBV INFECTED HEPATOCYTES OVEREXPRESSING SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE (2014) (0)
- Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity (2022) (0)
- Analysis of HCV-specific CD8+ T-cell cytolytic effector functions and their contribution to antiviral efficacy using a novel immunological model (2010) (0)
- Persistence of a transcriptional chronic scar on HCV-specific CD8+ T cells after DAA-mediated antigen removal (2020) (0)
- An international cohort study investigating the impact of age on clinical outcome in patients with hepatocellular carcinoma treated with sorafenib. (2020) (0)
- [Virus Hepatitis in Transition]. (2019) (0)
- Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox (2022) (0)
- CD154 expression reveals the presence of dysfunctional virus-specific CD4+ T cells during chronic HCV infection (2008) (0)
- Fate of HDV-specific CD8+ T cells during bulevirtide monotherapy in patients with chronic hepatitis delta (2022) (0)
- 208 ANALYSIS OF CD8+ T-CELL RESPONSES TO AFP, GLYPICAN-3, MAGE-A1 AND NY-ESO-1 IN PATIENTS WITH HEPATOCELLULAR CARCINOMA REVEALS A CLEAR HIERARCHY AND IMMUNODOMINANCE (2011) (0)
- T-Cell Response to Hepatitis B and C Virus: Lessons from the Chimpanzee Model (2005) (0)
- [RNA interference as antiviral strategy]. (2008) (0)
- 792 HBV-HCV COINFECTION: A NOVEL MODEL SYSTEM REVEALS INSIGHTS INTO IMMUNOLOGICAL MECHANISMS OF VIRAL INTERFERENCE (2012) (0)
- An alternative model for prediction of transplant-free survival in patients with implantation of transjugular intrahepatic portosystemic shunt (TIPS): The Freiburg risk score (2019) (0)
- Risk-stratified management of advanced hepatocellular carcinoma (HCC) (2018) (0)
- Comparison of different inhibitory pathways in hepatitis B virus-specific CD8+ T cell exhaustion (2014) (0)
- [Molecular biology in internal medicine. Report of the 24th Ludwig Heilmeyer Symposium of the Society for Progress in Internal Medicine]. (1997) (0)
- [Antibiotic therapy done right]. (2020) (0)
- Cytokine patterns of newly identified HEV-specific CD4 T cell epitope (2020) (0)
- [Suppressor T-cells: immunologic regulator cells and clinical perspectives]. (2004) (0)
- HCV-specific CD4 T cells show strong Tfh functionality after DAA-mediated viral clearance (2020) (0)
- 1349 VIROLOGIC RELAPSE IS HIGHLY CORRELATED WITH RESPONSE AT WEEK 4 AND 12 BUT NOT WITH IL28B GENOTYPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH PEG-INTERFERON/RIBAVIRIN (2011) (0)
- Parallel in vitro expansion of human hepatitis C virus specific FoxP3- effector memory and FoxP3+ regulatory CD8+ T cells on recognition of the same antigen (2007) (0)
- PO-1050: SBRT in liver cancer versus TACE. A prospective, non-randomised observational trial (HERACLES) (2020) (0)
- Efficacy and safety of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: a single center experience (2014) (0)
- The transcription factor TOX controls differentiation and maintenance of CD8 T-cells in chronic infections. (2019) (0)
- Ex vivo analysis of HCV-specific CD8+ T cell antiviral efficacy using a novel immunological model (2011) (0)
- 893 VARIATIONS OF VITAMIN D LEVELS IN GENOTYPE 1HEPATITIS C PATIENTS UNDERGOING ANTIVIRAL THERAPY CORRELATE WITH STAGE OF FIBROSIS BUT NOT WITH TREATMENT OUTCOME (2012) (0)
- Analysis of HLA-B27-Restricted Hepatitis C Virus-Specific CD8+ T Cell Responses in Acute Resolving Hepatitis (2005) (0)
- Magnitude and functionality of HEV-specific CD8+ and CD4+ T cell responses in asymptomatic blood donors resemble those in acute and symptomatic patients (2020) (0)
- [Hepatic amyloidosis as a rare differential diagnosis of progressive liver failure]. (2016) (0)
- Sa1780 Comprehensive T Helper Cell Profiling Reveals Concomitant Upregulation of Regulatory T Cells and TH17 Cells in Active Inflammatory Bowel Disease (2013) (0)
- Reduced mortality for over-the-scope clips (OTSC) versus surgery for refractory peptic ulcer bleeding: a retrospective study (2022) (0)
- PO-0811 SBRT compared to sorafenib in locally advanced hepatocellular carcinoma: a propensity score analysis (2019) (0)
- Frequency Is Linked to Naïve-Precursor T Cell + Hepatitis C Virus-Specific CD8 Immunodominance of HLA-A2-Restricted (2014) (0)
- P172 COMPARISON OF DIFFERENT IMMUNOREGULATORY PATHWAYS IN HEPATITIS B VIRUS-SPECIFIC CD8+ T-CELL FAILURE (2014) (0)
- Naturally occurring, tumor-specific CD8+ T cells in patients with hepatocellular carcinoma display a clear immunodominance (2012) (0)
- [Autoimmune diseases of the gastrointestinal tract]. (2022) (0)
- MAIT Cells in Viral Hepatitis and Liver Diseases. (2021) (0)
- Abstracts of the Scientific Meeting of the Bayliss & Starling Society. Guest Editor: Keith D. Buchanan, Belfast, Northern Ireland (1999) (0)
- [Endoscopic Ultrasound-Guided Fine Needle Aspiration]. (2017) (0)
- [Kaposi sarcoma: a virus-induced tumor?]. (1997) (0)
- Viral escape contributes to the failure of hepatitis D virus (HDV)-specific CD8+ T cells and drives population-level evolution of HDV (2019) (0)
- Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells (cid:1) (2008) (0)
- Soft-Tissue Infection with Abscesses Following a Cat Bite on the Forearm. (2021) (0)
- Full breadth analysis of AFP-specific CD8+ T cells in patients with hepatocellular carcinoma in the blood and in the liver (2008) (0)
- [Unusual cause of a PCT-elevation]. (2021) (0)
- [Viral Hepatitis: When to be Considered in Clinical Routine?] (2019) (0)
- Hepatic decompensation after transarterial radioembolization: A retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma (2022) (0)
- Differential Contribution of Progenitor and Terminal Subsets of Exhausted CD8+ T Cells in Chronic HBV versus HCV Infection (2016) (0)
- FRI-138-HBVcore-versus HBVpolymerase-specific CD8+ T cells differ in chronically HBV-infected patients (2019) (0)
- [784] EXHAUSTION OF VIRUS SPECIFIC CD4+ T CELLS DURING ACUTE HEPATITIS C (2007) (0)
- Impact of tumor markers in diagnosis of patients with hepatocellular carcinoma (HCC) and their clinicopathologic correlation: an interim analysis (2012) (0)
- [Urinary and fecal incontinence]. (2022) (0)
- Reply: TIPS and liver transplantation should always be discussed together. (2021) (0)
- Characterization and Functional Modulation of HBV-Specific CD4+ T Cell Responses (2015) (0)
- Blood reelin levels in the progression of chronic liver disease (2020) (0)
- Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma (2017) (0)
- Fritz von Weizsäcker 1960-2019: An exceptional physician-scientist. (2020) (0)
- P071 Intestinal CD8+ T cell exhaustion is linked to disease activity in ulcerative colitis (2022) (0)
- Determinants of CD8+ T cell exhaustion during chronic hepatitis C virus infection (2010) (0)
- P-215 phase 2 HEPANOVA study of tumor treating fields (TTFields, 150 kHz) concomitant with sorafenib in advanced hepatocellular carcinoma (HCC): Interim safety analysis (2020) (0)
- A protective HLA-B*27 restricted epitope contributes to viral control in chronic HCV infection despite presence of viral escape mutations and is characterized by a unique T cell phenotype (2014) (0)
- Identification of CD8+ T-cell epitopes specific for hepatitis C virus genotype 4 (2015) (0)
- Hepatitis C Virus (Flaviviridae): Host Immune Responses to Hepatitis C Virus (2009) (0)
- [Fibroscan of the liver]. (2015) (0)
- IL-3 PHYLOGENETIC ANALYSIS OF EUPHORBIA PALLASII USING 5 . 8 S RIBOSOMAL GENE , UNIVERSAL PRIMER SET OF THE ITS REGION NUCLEAR DNA SEQUENCE (2017) (0)
- Editorial: acute non‐cirrhotic and non‐malignant portal vein thrombosis––who should be candidates for interventional treatment? Authors’ reply (2020) (0)
- 286 DOMINANT CYTOLYTIC ANTIVIRAL EFFECTOR FUNCTIONS IN A NOVEL IMMUNOLOGICAL MODEL OF HBV INFECTION (2011) (0)
- [CD8(+) T cell differentiation in viral infections]. (2006) (0)
- The breadth of CD8+ T cell responses in chronic and resolved HBV infection (2015) (0)
- Sa1177: HIGH FAT DIET SHAPES GUT MICROBIOME AND ACCELERATES PROGRESSION FROM BARRETT ESOPHAGUS TO ADENOCARCINOMA VIA SYSTEMIC BILE ACIDS (2022) (0)
- Rapid communications Transfusion-transmitted hepatitis E in Germany , 2013 (2014) (0)
- HLA-A26 restricted HCV-specific CD8+ T cell responses in acute and chronic HCV infection (2006) (0)
- Hepatitis C Virus (HCV) Sequence Variation Induces an HCV-Specific T-Cell Phenotype Analogous to Spontaneous Resolution (2011) (0)
- 483 IMPORTANCE OF HCV RNA ASSAY CHARACTERISTICS AND DIFFERENCES BETWEEN ASSAYS FOR RESPONSE GUIDED THERAPY OF CHRONIC HEPATITIS C (2011) (0)
- Persistence of hepatitis C after homolgous monoclonal re-challenge associated with the emergence of new virus variants (2003) (0)
- NS5A resistance patterns and treatment outcomes in DAA-naive genotype 1a chronic hepatitis C patients with and without baseline resistance-associated substitutions (2018) (0)
- Induction of MxA Gene Expression by Influenza A Virus Requires Type I or Type III Interferon Signaling (cid:1) (2007) (0)
- [Hepatology: from basic science to the clinic]. (2012) (0)
- Hepatitis B Virus-Infected HepG2 hNTCP Cells Serve as a Novel Immunological Tool To Analyze the Antiviral Efficacy of CD8 (cid:2) T Cells In Vitro (2015) (0)
- SARS-CoV-2-specific adaptive immune response after mRNA vaccination in liver transplanted patients (2022) (0)
- Inflammation and Cancer: Falk Workshop, Hamburg, January 2012 (2012) (0)
- Role of the Immune System in Hepatocellular Carcinoma: Implications for Existing and Novel Therapies (2016) (0)
- [Colorectal carcinoma]. (2021) (0)
- Vaccine-Induced HCV-Specific CD8+ T Cell Response Restricted by the Protective HLA Allele B*27: Broad Cross-Recognition of Evolving Viral Variants (2016) (0)
- Intrahepatic compartmentalization of IL-17-producing CD4+ and CD8+ T cells in chronic HCV infection (2009) (0)
- Nivolumab plus palliative Chemotherapie (2021) (0)
- Mo1883 – Clinical Response to Ustekinumab in Crohn’s Disease is Linked to a Dose Dependent Reduction of T Follicular Helper Cells (2019) (0)
- 3 POPULATIONAL ANALYSIS REVEALS A LINK BETWEEN COMPLEX VIRAL ESCAPE FROM CD8+ T-CELL RESPONSES AND PROTECTION IN HCV INFECTION (2011) (0)
- The patient as partner - clinical care respecting patient autonomy (2005) (0)
- Influence of type 2 diabetes mellitus on tumour characteristics and outcomes in patients with hepatocellular carcinoma (2013) (0)
- PO-0767: Local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis (2018) (0)
- Peptides and Definition of Their Peptide Molecules That Bind HLA Supertype Identification of Five Different Patr Class I (2000) (0)
- P0392 : Transarterial chemoembolisation in patients with metastatic hepatocellular carcinoma (2015) (0)
- Title Page / Table of Contents / Guidelines for Authors / Imprint (2014) (0)
- [Diseases of the gall-bladder and bile ducts]. (2020) (0)
- [Diagnosis and treatment of hepatocellular carcinoma]. (2004) (0)
- Natural course and prognostic factors in patients with cholestatic liver disease – experience from a single center study (2015) (0)
- Holmium laser vaporization and percutaneous removal of a migrated endothelialized biliary self-expanding metal stent (2019) (0)
- Analysis of the Evolutionary Forces in an Immunodominant CD8 Epitope in Hepatitis C Virus at a Population Level (2011) (0)
- Function is the key: impact of interferon on HCV-specific CD8+ T cells during acute HCV infection (2008) (0)
- Survival prediction using the Freiburg index of post-TIPS survival (FIPS) in critically ill patients with acute- on chronic liver failure: A retrospective observational study (2022) (0)
- Hepatitis E in Haematological Patients in Europe: A Multicentre Study (2016) (0)
- Over-The-Scope Clips (OTSC©) Versus Surgery for Refractory Peptic Ulcer Bleeding (2021) (0)
- HLA-B*27 subtype specificity determines the targeting of HLA-B*27 restricted HCV-specific CD8+ T cell epitopes (2013) (0)
- Natural history of chronic hepatitis B virus infection (2014) (0)
- Functional Mapping of Hepatitis C Virus (HCV)-Dendritic Cell Interaction Using HCV-like Particles (2005) (0)
- Virushepatitis A–E (2006) (0)
- Virushepatitis@@@Viral hepatitis (2006) (0)
- [Therapy refractory ascites: insertion of a tunneled long-term peritoneal catheter]. (2009) (0)
- 90 IMMUNODOMINANCE OF HLA-A*0201 RESTRICTED HEPATITIS C VIRUS-SPECIFIC CD8+ T CELL RESPONSES IS DETERMINED BY THE NAIVE PRECURSOR FREQUENCY (2011) (0)
- FRI-208-Predictors of treatment response during addition of pegylated Interferon alfa-2a to an onging nucleos (t)id treatment in chronic hepatitis B: Results from the PADD-ON trial (2019) (0)
- CD161 expressing CD4+ CD25hi T cells accumulate in the liver of obese patients with NASH (2022) (0)
- The Breadth of CD8+ T Cell Responses in Chronic and Resolved Hepatitis B Virus Infection (2016) (0)
- Clinical Hepatology Practice in 2016: From Science to Therapy: Symposium 204, Birmingham, September 2016 (2017) (0)
- Abstracts of the Annual Congress of the British Society for Immunology. December 6-10, 2010. Liverpool, United Kingdom. (2010) (0)
- [Immunological T cell analyses -- current state and clinical relevance]. (2006) (0)
- AFP-specific CD4+ T-cell immunity in the blood and liver of patients with Hepatocellular Carcinoma (2010) (0)
- P200 SUPPRESSIVE EFFECT OF IL-10 ON THE PRIMING OF NAIVE HCV-SPECIFIC CD8+ T-CELLS (2014) (0)
- Analysis of Successful Virus-Specific CD8+ T Cell Responses in acute HBV infection (2006) (0)
- HLA-B27 has a dominant role in restricting strong CD8+ T cell responses and driving viral escape in hepatitis B virus infection (2012) (0)
- Identification of a TSCM phenotype HCV-specific CD8+T cell response with superior functionality in chronic HCV infection [Abstract] (2014) (0)
- VIRAL FITNESS COST AND T CELL CROSS-RECOGNITION LIMIT VIRAL ESCAPE WITHIN A PROTECTIVE HLA-B27 RESTRICTED HEPATITIS C VIRUS SPECIFIC CD8+T CELL EPITOPE (2008) (0)
- EFFECTIVE REDUCTION OF ESOPHAGEAL STENT MIGRATION RATE WITH A NOVEL OVER-THE-SCOPE FIXATION DEVICE (STENTFIX OTSC) (2022) (0)
- [Angiostatin. A biological inhibitor of tumor angiogenesis]. (1997) (0)
- Hepatische Amyloidose als seltene Differenzialdiagnose bei progredientem Leberversagen (2016) (0)
- Two-sided sponge (TSS) treatment - a modified endoscopic vacuum technique for anastomotic leaks and perforations in the upper gastrointestinal tract and small bowel (2020) (0)
- Priming persistence of HCV (2015) (0)
- CD4+ T cells don't always help (2007) (0)
- Presence of naive-like HBV-specific CD8+ T cells in chronically infected patients despite ongoing viral replication (2015) (0)
- [Quorum sensing: a mechanism of communication between bacteria]. (1998) (0)
- The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression (2019) (0)
- [Serologic pitfalls in the diagnosis of hepatopathy of uncertain origin]. (2013) (0)
- Restoration of Hepatitis C virus-specific CD8+ T-cell responses in patients undergoing IFN-free antiviral therapy (2014) (0)
- A Memory-Like Subset Dominates the HCV-Specific CD8+ T-Cell Compartment after DAA-Mediated Antigen Removal (2016) (0)
- Hepatitis C Virus (HCV) Sequence Variation Induces an HCV-Specific T-Cell Phenotype Analogous to Spontaneous Resolution (vol 84, pg 1656, 2010) (2011) (0)
- Regulatory T Cells Suppress Virus-Specific CD8+ T Cell Proliferation During Chronic Hepatitis C Virus Infection (2005) (0)
- Cholestatic liver diseases: primary biliary cirrhosis (2002) (0)
- Comprehensive analysis of the intrahepatic virus-specific CD8+ T-cell response during chronic hepatitis C virus infection (2004) (0)
- Maintenance of virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154 (2009) (0)
- FRI-150-Association of the immunodominant HLA-B35:01 restricted CD8+ T cell epitope with clustered viral evolution in HBV polymerase (2019) (0)
- Protection from persistent hepatitis C virus infection by HLA class I: The need for multiple escape mutations in immunodominant T cell epitopes is a common feature (2011) (0)
- Clearance of chronic HCV infection leads to an expansion of a follicular T helper cell memory phenotype in HCV-specific CD4 T cells (2019) (0)
- P0487 : Dominance of HLA-B restricted virus-specific CD8+ T cell epitopes in chronic HBV infection (2015) (0)
- Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis (2018) (0)
- Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis (2022) (0)
- Scavenger Receptor Class B Type I is a Hepatitis C Virus Receptor on Human Dendritic Cells (2006) (0)
- The GALAD Score as Potential Screening Test for Hepatocellular Carcinoma in Nonalcoholic Steatohepatitis: An International Multicenter Study (2019) (0)
- 694 DIAGNOSTIC ACCURACY OF HCC BIOMARKERS DEPENDS ON THE ETIOLOGY OF LIVER DISEASE: AN INTERIM ANALYSIS (2012) (0)
- O12 RESTORATION OF HCV-SPECIFIC CD8+ T-CELL RESPONSES WITH INTERFERON-FREE TREATMENT OF HEPATITIS C (2014) (0)
- Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma – authors' reply (2015) (0)
- Evaluation of Laboratory and Sonographic Parameters for Detection of Portal Hypertension in Patients with Common Variable Immunodeficiency (2022) (0)
- 40 HLA-B27 HAS A DOMINANT ROLE IN RESTRICTING STRONG CD8+ T CELL RESPONSES AND DRIVING VIRAL ESCAPE IN HEPATITIS B VIRUS INFECTION (2012) (0)
- Dominance of HLA-B restricted virus-specific CD8+ T cell epitopes in chronic HBV infection (2015) (0)
- FRI-154-Augmentation of HBV-specific CD4 T cell responses via combined 0X40 stimulation and PD-L1 blockade (2019) (0)
- Tailoring of hepatitis C virus escape from an HLA-B27 restricted CD8+ T cell epitope (2010) (0)
- Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma (2020) (0)
- 395 Intrahepatic CD8+ T cell failure: T cell dysfunction and viral escape during chronic HCV infection (2003) (0)
- Enolase represents a metabolic checkpoint controlling the differential exhaustion of virus-specific CD8+ T cells in viral hepatitis (2022) (0)
- Responsiveness of HBV-specific CD8+ T cells to PD1 pathway blockade is linked to TCF1 expression (2017) (0)
- Cholestatic liver diseases: primary sclerosing cholangitis (2002) (0)
- P147 CD4+ T CELL EGRESS THROUGH HEPATIC EPITHELIA HAS PROFOUND IMPLICATIONS FOR PHENOTYPE AND FUNCTION (2014) (0)
- Insights From Antiviral Therapy into Immune Responses to HBV and HCV Infection (2019) (0)
- EASL innovation award recipient 2022: Prof. Martin Rössle. (2022) (0)
- [From Molecuar to Natural Medicine]. (2018) (0)
- CD161+gamma-delta T CELLS: DEFINING THEIR ROLE IN PATIENTS WITH AND WITHOUT CHRONIC HEPATITIS C (2011) (0)
- TOX expression on HBV specific CD8+ T cells is linked to clinical stage of chronic HBV infection (2020) (0)
- [Hepatitis B viral load as a risk factor for liver cirrhosis]. (2008) (0)
- PS-028-Viral escape contributes to the failure of hepatitis D virus-specific CD8+ T-cells and drives evolution of HDV (2019) (0)
- Discovery of conserved HDV-specific CD8+ T-cell epitopes in HBV/HDV infection (2021) (0)
- Announcement and Erratum (1999) (0)
- Contents Vol. 30, 2014 (2014) (0)
- 361 REGULATORY T-CELLS DIFFERENTIALLY REGULATE PROLIFERATION AND CYTOKINE PRODUCTION OF HCC-SPECIFIC CD8+ T-CELLS (2013) (0)
- [Cholestatic liver diseases: diagnosis and therapy of primary sclerosing cholangitis]. (2002) (0)
- The Role of Stereotactic Body Radiotherapy (SBRT) in Locally Advanced Hepatocellular Carcinoma Versus Transarterial Chemoembolization (TACE): A Prospective, Non-Randomized Observational Trial (HERACLES) (2019) (0)
- Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma (2018) (0)
- Reply: External validation of the Freiburg index of post-TIPS survival and Freiburg index of post-TIPS survival: the first score for individual prediction and a complementary tool for risk stratification. (2021) (0)
- 271 HIGH EXPRESSION OF DIPEPTIDYLPEPTIDASE IV (CD26) ON INTRAHEPATIC TH17 CELLS IN INFLAMMATORY LIVER DISEASES (2011) (0)
- Protection by HLA-B27 in HCV infection: role of virological and immunological factors (2008) (0)
- From Viral Hepatitis to Chronic Inflammation and Liver Cancer (2019) (0)
- Reduced survival in patients with proton pump inhibitor treatment following implantation of a transjugular intrahepatic portosystemic shunt (2021) (0)
- [Systemic treatment for hepatocellular carcinoma]. (2003) (0)
- O158 A PROTECTIVE HLA-B*27 EPITOPE CONTRIBUTES TO HCV CONTROL IN CHRONIC INFECTION DESPITE PRESENCE OF VIRAL ESCAPE MUTATIONS AND IS CHARACTERIZED BY A UNIQUE T-CELL PHENOTYPE (2014) (0)
- ArgoCap - feasibility and safety of a novel over-the-scope device to facilitate endoscopic APC treatment. (2023) (0)
- Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients (2023) (0)
- Boosting compromised SARS-CoV-2-specific T cell immunity in liver transplant recipients by mRNA vaccination (2023) (0)
- Treating hepatitis D with bulevirtide - Real-world experience from 114 patients. (2023) (0)
- Adaptive NK cells with decreased antitumor activity are expanded in HBV-associated HCC (2018) (0)
- Evidence of a dysfunctional Tfh cell response after decompensation of liver cirrhosis (2018) (0)
- Expansion of HCV-specific T cells with a follicular T helper cell phenotype after DAA mediated antigen removal (2018) (0)
- Characterization of the HEV-specific CD8 T-cell response in acute and chronic Hepatitis E virus infection (2018) (0)
- Comparison of local tumor control in patients with HCC treated with stereotactic body radiation or TACE: a propensity score analysis (2018) (0)
- DOP70 High-dimensional analysis reveals a novel signature for IL-17 producing CD8 T cells in inflammatory bowel disease (2020) (0)
- [Diversity in gastroenterology - A focus on inflammatory bowel diseases]. (2023) (0)
- MAGE-specific CD8 T cells are not exhausted in HCC patients (2018) (0)
- Subset diversification of virus-specific CD8+ T-cells in chronic HCV monoinfection and HCV/HIV coinfection (2016) (0)
- Efficacy of variceal embolisation in patients with TIPS implantation: a propensity score analysis (2018) (0)
- Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection (2021) (0)
- P084 Clinical response to Ustekinumab in Crohn’s disease is linked to a dose-dependent reduction of T follicular helper cells (2019) (0)
- The impact of ERAP1 polymorphisms on virus-specific CD8+ T cell responses in an HLA*B27+ patient with acute hepatitis C virus infection (2016) (0)
- Micro-RNA Landscape of Hepatocellular Carcinoma-Derived Extracellular Vesicles (2023) (0)
- Metabolic programming of exhausted CD8+ T cells in chronic viral hepatitis (2020) (0)
- IL-18, CXCL-8 and CXCL-10 plasma levels decrease in patients with chronic Hepatitis C virus infection undergoing DAA therapy (2016) (0)
- Major Histocompatibility Complex (MHC) Class I-associated phosphopeptides as potential targets for immunotherapy in hepatocellular carcinoma (HCC) (2016) (0)
- The ALBI score: a new tool for decision making after TACE (2016) (0)
- Antigen-specificity determines virus-specific CD8 T-cell exhaustion profile in chronic HBV infection (2018) (0)
- HLA-B*27-restricted CD8+ T cell response against hepatitis B virus: viral escape as central mechanism of T cell failure (2021) (0)
- Inefficient induction of TAA-specific CD8+ T-cell responses in hepatocellular carcinoma (2019) (0)
- A TCF1 expressing memory-like population of Hepatitis C virus-specific CD8+ T cells is maintained after DAA-mediated viral elimination (2016) (0)
- Long-term PPI treatment is a risk factor for acute-on-chronic liver failure in patients with advanced cirrhosis: a propensity score matched analysis (2023) (0)
- MCAM is a prognostic serum biomarker in patients with liver cirrhosis and HCC (2023) (0)
- Phenotypic and functional differences of HBVcore- versus HBVpolymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load (2019) (0)
- The role of phosphopeptide neoantigens in cancer immunotherapy (2018) (0)
- Sustained Vd1 and Vd2 T-cell profiles in chronic viral hepatitis (2016) (0)
- The metabolic signature of adaptive NK cells is maintained during chronic viral hepatitis (2016) (0)
- Follicular T helper cells in patients with cholestatic liver disease – a comparative study (2016) (0)
- The transcription factor c-Jun/AP-1 affects non-alcoholic steatohepatitis (NASH) and liver fibrosis in a cell-type specific manner (2018) (0)
- Immune escape pathways from the HBV core18-27 CD8 T cell response are driven by individual HLA class I alleles (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert Thimme?
Robert Thimme is affiliated with the following schools: